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Abstract
Colorectal cancer (CRC) screening uptake
among minorities and those with lower incomes
is suboptimal. Behavioral interventions specific-
ally tailored to these populations can increase
screening rates and save lives. The Precaution
Adoption Process Model (PAPM) allows
assignment of a decisional stage for adoption of
a behavior such as CRC screening. Here, we
characterize the PAPM decisional stage distribu-
tion among 470 low income, racially and ethnic-
ally diverse study participants at intake into a
behavioral intervention study designed to in-
crease CRC screening uptake. We staged partici-
pants for stool blood test (SBT) and colonoscopy
separately and used the highest stage for the
two tests as the ‘overall’ stage for CRC screening.
For SBT, sex, language (English versus Spanish)
and doctor recommendation were significantly
related to PAPM stage for CRC screening.
For colonoscopy, language, education level,
doctor recommendation and self-efficacy were
related to stage. For overall CRC screening
stage, all the variables associated with either
SBT or colonoscopy, with the exception of lan-
guage were significant. This study suggests at-
tending to these key variables in designing
interventions to promote CRC screening, par-
ticularly with respect to medically underserved
populations.
Introduction
Colorectal cancer (CRC), the second most common
cause of cancer death in the United States for
cancer affecting both men and women, is prevent-
able and curable [1]. Minorities and those with low
incomes have lower rates of screening and higher
rates of CRC mortality than the majority popula-
tion [2]. Many factors contribute to suboptimal
uptake of cancer screening within the nation’s
underserved subgroups: inadequate access to
screening services, limited awareness of screening
guidelines and requirements and aversion to fea-
tures of screening procedures may all play import-
ant roles [3–5]. Less studied is the decision-making
process that screening eligible adults go through as
they consider getting tests within the health care
system. Although research has shown a strong re-
lationship between provider recommendations and
CRC screening completion, there are many indi-
viduals who receive a provider recommendation,
yet do not complete testing [6–8]. In other situ-
ations, screening eligible individuals may receive
a recommendation, decide to move forward with
testing but have delays of months or even years
between the recommendation, the decision and
eventual screening completion.
For those receiving a physician CRC screening
recommendation, lack of awareness of CRC risk,
preventability and screening options may lead to
low personal relevance, low motivation and low
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perceived behavioral control [9]. Even with aware-
ness and education, beliefs, such as cancer fatalism
and barriers associated with poverty may affect
CRC screening completion [10, 11]. Physician or
healthcare system programs to promote CRC
screening are challenged by the need to increase
awareness, educate, address specific beliefs and bar-
riers and provide access to screening.
The concept of tailoring information to patients’
stage of readiness and decision making is receiving
increasing attention [12]. A useful model for evalu-
ating people’s stage of readiness for adopting pre-
ventive behaviors (precautions) like CRC screening
is the Precaution Adoption Process Model (PAPM)
[13, 14]. The PAPM is a stage theory of health be-
havior, which describes the process of behavior
change as a series of seven steps or stages (Fig. 1)
[13]. We chose the PAPM because of our prior
qualitative studies and because this model allowed
us to differentiate between participants who are un-
aware of recommendations (Stage 1) and those who
are simply unengaged with the issue of CRC screen-
ing (Stage 2). In addition, unlike other behavioral
theories, the PAPM framework allows us to identify
those who are aware of the screening methods and
their CRC risk yet have decided not to be screened
(Stage 4) [15].
The PAPM has been previously used to evaluate
decisional stage for CRC screening in primary care
patients in Massachusetts, in participants complet-
ing the National Cancer Institute’s Health
Information National Trends Survey and in an inter-
vention in Adelaide, Australia [16–18]. The studies
by Ferrer et al. and Costanza et al. were undertaken
in the United States. Both studies used information
from participants who were primarily white and
non-Hispanic (85% and 94%, respectively). Trauth
et al. also explored CRC screening stage in a low-
income population in the United States (also
predominantly white, 90%) using a different
stage model, the Transtheoretical Model (TTM),
from which the PAPM was developed [19]. In the
TTM, people who are unaware of an issue/risk and
those who are aware but not considering making a
change in their behavior are grouped into the
precontemplation stage and cannot be distin-
guished from one another. However, Trauth et al.
subdivided their precontemplation participants into
unaware (comparable to PAPM Stage 1) and
precontemplation (comparable to PAPM Stage 2).
Participants in all three of the US studies were found
to be distributed throughout the stages with numer-
ous factors relating to stage, such as worry/per-
ceived risk, fatalism, prior screening history for
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Fig. 1. Description of the stages of the PAPM that were used to stage participants for CRC screening in this study.
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other cancers and some demographic factors (sex,
financial situation, education level, marital status,
etc.).
Here, we describe analysis of data on PAPM sta-
ging collected at enrollment in a large CRC screen-
ing study comprised entirely of screening eligible
low-income patients recruited from urban safety-net
clinics. This project provided a unique opportunity
to explore the baseline decisional stage distribution
in low-income population that was less than one-
third white. Prior to participation in a motivational
intervention to improve CRC screening uptake,
study participants were staged for CRC screening
decision making using PAPM questions. PAPM sta-
ging questions were asked for both colonoscopy and
‘home stool blood tests’ [SBT: refers to fecal occult
blood testing (FOBT) or fecal immunochemical
testing (FIT), kits performed at home; for the sake
of consistency, we use SBT hereafter to refer to FIT
and FOBT]. Because all participants were age 50 or
over (one participant was 49 at enrollment) but not
current with CRC screening, we anticipated that the
majority of participants would fall within Stages 1–
4, recognizing that some would have already
decided to be screened by a particular method
(Stage 5, Fig. 1) but would have not yet completed
screening (FIT or colonoscopy was offered at no
cost to participants in the study). Here, we describe
PAPM decisional stage distribution prior to begin-
ning the intervention and discuss the variables asso-
ciated with decisional stage at intake in this racially
and ethnically diverse, low-income sample. We are
not aware of other studies describing CRC decisio-
nal stage distribution or the correlates of PAPM
stage among such a diverse group of underserved
patients or as part of efforts to reduce CRC screening
disparities for minorities.
Methods
This study was approved by the Institutional Review
Board of the University of Kansas Medical Center.
We recruited a convenience sample of 470 partici-
pants from the waiting rooms of nine safety-net
clinics in a large metropolitan area between 2008
and 2010. Study staff approached potential partici-
pants and asked them to complete a questionnaire to
determine eligibility (i.e. age 50 or over, not up-to-
date with CRC screening). The eligibility form also
assessed participants’ awareness of CRC screening
options and PAPM decisional stage for CRC screen-
ing. We assessed PAPM decisional stage for SBT,
colonoscopy, and created an ‘overall’ CRC screen-
ing decisional stage by combining the answers for
both SBT and colonoscopy. PAPM stages were
determined to be ‘unaware’, ‘unengaged’,
‘deciding’, ‘decided not to screen’ or ‘decided to
be screened’ (PAPM Stages 1–5; see Fig. 1) based
on questions asked for each test modality: i.e. ‘Have
you thought about doing/having a stool blood test/
colonoscopy in the future?’ and ‘Which of the fol-
lowing statements best describes your thoughts
about doing an at-home stool blood test in the fu-
ture?’ Items were adapted from the work of
Weinstein, Costanza and Myers [14, 16, 20]. This
work is based on data from the participants
(n¼ 470) who were eligible for and consented to
participate in the study; no data were retained for
those who were ineligible or who declined to
participate.
Upon consent and enrollment into the study (after
completion of the eligibility questionnaire), partici-
pants completed additional surveys on touchscreen
computers. The touchscreen survey collected demo-
graphic information, and all variables were mea-
sured by self-report from participants. Cancer
fatalism items assessed attitudes toward getting
cancer and the effectiveness of treatments. We
adapted items from the Powe Cancer Fatalism
Inventory with all 10 cancer fatalism items mea-
sured by Likert scale [11, 21]. These included:
‘I think if someone has cancer, it is already too
late to get treated’ and ‘I think many people who
have cancer treatment get better and go on with their
lives’. The responses to the fatalism questions were
reverse coded as necessary and summed; higher
scores indicated more fatalistic cancer beliefs.
Perceived self-efficacy refers to participants’ self-
confidence in their ability to complete a test. Self-
efficacy was assessed with one question: ‘If you
decided you wanted to get colon cancer screening,
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how likely is it that you could do a test?’ adapted
from prior multi-item self-efficacy measures
[22–24]. For CRC perceived risk, we utilized a
three-item scale developed by Vernon et al. [25].
Example items included ‘How likely do you think
it is that you will develop colon cancer in the
future?’ and ‘How often do you worry about getting
colon cancer?’
Theoretical framework
The PAPM suggests that adopting new precautions,
such as CRC screening, requires conscious aware-
ness, decision and deliberate action (Fig. 1) [13, 14].
The PAPM also suggests that people in different
decisional stages may benefit from different kinds
of interventions. Initially (Stage 1), people need gen-
eral information about the existence of CRC and
screening. As they gain awareness (Stage 2), they
may be more receptive to information about screen-
ing guidelines, risk factors for CRC and mortality
associated with CRC. Engagement with relevant in-
formation should motivate people to decide whether
or not to screen (Stage 3). In this stage, most people
will evaluate the pros and cons of screening; elab-
oration of the potential risks and benefits of action
may be helpful in motivating people to decide to be
screened (Stage 5), or may lead some people to
decide not to be screened (Stage 4). Once people
have decided to be screened (Stage 5), they must
overcome any barriers to screening and take what-
ever action is necessary to be screened (Stage 6).
Finally, after having overcome the barriers and
implemented a behavior, people will need to face
various challenges to maintaining the behavior
(Stage 7).
PAPM staging
The staging schema is depicted in Fig. 2. Based on
their answers to the questions on the screening form,
participants could be placed in any of the PAPM
stages from 1 to 5 (Fig. 1). Participants were
staged for SBT, colonoscopy and overall CRC
screening. Overall screening stage represented
the most advanced stage of screening adoption re-
ported by each participant, whether that was for
colonoscopy or SBT. Participants who were in
Stage 4 (decided not to be screened) would have
been considered Stage 4 for overall screening if
they were in Stage 4 for both SBT and colonoscopy
(n¼ 0; Fig. 3A).
Analyses
We applied polytomous logistic regression with
baseline logit models to look for variables asso-
ciated with decisional stage for adoption of CRC
screening at intake. Stage 1 (unaware) was chosen
as the reference category. Twelve explanatory vari-
ables were included in the models: clinic where the
participant was recruited; age; sex; marital status;
education; employment status; insured status; lan-
guage (English or Spanish); report of a prior doctor’s
recommendation to be screened for CRC;
self-efficacy for CRC screening; perceived risk of
CRC and cancer fatalism score (see Table I). Note
that we combined race and ethnicity information
into a single race/ethnicity variable for analysis.
Race/ethnicity was highly overlapping with lan-
guage, requiring that we include only one of these
variables in our analyses to avoid the issue of co-
linearity. We chose to use language rather than race/
ethnicity because of predictive power and sparse-
ness (there were 14 participants in the ‘other’ race/
ethnicity group that would have been discarded if
race/ethnicity was used as a predictor).
Results
Participant characteristics
Participant characteristics (n¼ 470) are listed in
Table I. The study sample was racially and ethnic-
ally diverse (note that race/ethnicity information
was combined into one race/ethnicity variable for
analysis, see ‘Methods’ section). Most of the partici-
pants spoke English as their primary language
(n¼ 364, 77.4%), whereas 22.6% (n¼ 106) spoke
Spanish. The majority of the participants rated them-
selves as having ‘very high’ self-efficacy (being
very likely to complete a CRC screening test upon
deciding to do so; n¼ 264, 56.2%). On a scale ran-
ging from 3 to 9, with 9 meaning the highest
CRC screening decisional stage at intervention intake
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perceived susceptibility to CRC, the mean perceived
risk in the study sample was 4.9 (±1.5). The mean
fatalism score was 24.1 (±3.4) on a scale ranging
from 10 to 30, with higher numbers indicating
more fatalistic beliefs.
Stage distributions
The PAPM stage distributions of the 470 study par-
ticipants for SBT, colonoscopy and overall screen-
ing are depicted in Fig. 3, and the numbers of
participants in each stage for each test are shown
in Fig. 2. All participants were staged for both
tests and therefore had a separate stage for SBT,
colonoscopy and overall. Strikingly, 56.2%
(n¼ 264) of participants had not heard of SBT at
intake (Stage 1), whereas only 21.5% (n¼ 101) of
participants had not heard of colonoscopy. A size-
able minority of participants (17.7%; n¼ 83) were
unaware of either screening alternative, placing
them in Stage 1 overall. Interestingly, approximately
Fig. 2. PAPM staging schema including the number (and percent) of participants at each stage for each testing modality and overall.
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one-third of Spanish-speaking participants were in
Stage 1 for overall screening, with three quarters
being in Stage 1 for SBT (Fig. 3C). Participants
who were aware but unengaged were more evenly
distributed across test type (Stage 2). Fewer partici-
pants were undecided for SBT (Stage 3) than for
colonoscopy and overall. Very few participants
had decided against screening (Stage 4): 0.2%
(n¼ 1) for SBT and 1.3% (n¼ 6) for colonoscopy.
None of these participants had decided against
screening using both tests (overall), meaning that
those who had decided against colonoscopy had
not decided against SBT and vice versa. Among
participants who had already decided to screen
(Stage 5), 10.9% (n¼ 51) had decided to be
screened by SBT and 39.2% (n¼ 184) by colonos-
copy. (Note that participants could indicate that they
wanted both SBT and colonoscopy; they were not
forced to choose one test modality or the other at this
point in time.) Overall, 44.7% (n¼ 210) expressed
an intention to be screened by one or both methods
at intake (Stage 5).
SBT decisional stage
At intake, decisional stage for SBT was significantly
associated with sex [Wald 2ð3Þ ¼ 14:1, P¼ 0.003],
language [Wald 2ð3Þ ¼ 11:7, P¼ 0.009] and
doctor’s recommendation [Wald 2ð3Þ ¼ 32:0,
P< 0.0001]. Baseline logit models were adjusted
for appropriate variables (Table II). After adjust-
ment, women were more likely than men to be in
Stages 2 or 3 as opposed to Stage 1. Compared to
Spanish-speaking participants, English-speaking
participants were less likely to be in Stage 1 and
more likely to be in Stages 2 or 5 (Table II;
Fig. 3B and C). Participants whose doctors had rec-
ommended CRC screening in the past were more
likely to be in Stages 2, 3 and 5 versus Stage 1
than their counterparts without a doctor’s
recommendation.
Colonoscopy decisional stage
At intake, decisional stage for colonoscopy was sig-
nificantly associated with language [Wald
2ð3Þ ¼ 9:4, P¼ 0.024], education [Wald
2ð3Þ ¼ 12:6, P¼ 0.006], doctor’s recommendation
[Wald 2ð3Þ ¼ 22:9, P< 0.0001] and self-efficacy
[Wald 2ð3Þ ¼ 13:7, P¼ 0.003]. Baseline logit
models were adjusted for appropriate variables
(Table II). After adjustment, English-speaking par-
ticipants were less likely than Spanish-speaking par-
ticipants to be in Stage 1 and more likely to be in
Stage 2, for colonoscopy (Table II; Fig. 3B and C).
Compared to participants with high school diploma/
Fig. 3. PAPM stage distribution of participants at baseline. (A) Stage distribution for all participants. (B) Stage distribution for English-
speaking participants. (C) Stage distribution for Spanish-speaking participants.
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General Educational Development (GED) attain-
ment or lower education levels, participants who
completed college or received even higher educa-
tion levels were more likely to be in Stage 3 and
Stage 5 versus Stage 1 for colonoscopy but were
not significantly more likely to be in Stage 2
than in Stage 1. Participants whose doctors had
recommended CRC screening in the past were
more likely to be in Stages 2, 3 and 5, respectively,
than their counterparts without a doctor’s recom-
mendation. Finally, participants who ranked them-
selves at the highest level of self-efficacy for CRC
screening were more likely to be in Stage 5 (decided
to screen by colonoscopy) than in Stage 1 (unaware
of colonoscopy screening).
Overall CRC screening decisional stage
At intake, overall decisional stage for either CRC
screening test was significantly associated with sex
[Wald 2ð3Þ ¼ 14:8, P¼ 0.002], education [Wald
2ð3Þ ¼ 15:9, P¼ 0.001], doctor’s recommendation
[Wald 2ð3Þ ¼ 35:1, P< 0.0001] and self-efficacy
[Wald 2ð3Þ ¼ 9:0, P¼ 0.029]. Baseline logit
models were adjusted for appropriate variables
(Table II). After adjustment, women were more
likely than men to be in Stages 2, 3 or 5 as opposed
to Stage 1 (Table II). As in the colonoscopy staging
model, participants who completed college or at-
tained even higher education levels were more
likely to be in Stage 3 and Stage 5 versus Stage 1
as compared to participants with high school dip-
loma/GED or lower education levels but were not
significantly more likely to be in Stage 2.
Participants whose doctors had recommended
CRC screening in the past were more likely to be
in Stages 2, 3 and 5 for overall stage than their coun-
terparts without a doctor’s recommendation after
adjusting the other variables. Participants who
ranked themselves as having very high self-efficacy
for CRC screening were more likely to be in Stage 5
than in Stage 1 for overall stage compared to par-
ticipants who placed their self-efficacy below very
high (Table II). The odds in favor of being in Stages
2 or 3 against Stage 1 for overall screening were not
significantly associated with self-efficacy.
Discussion
Stage models assume that people go through a pro-
gression of thoughts or stages when considering a
health behavior and ultimately taking action.
Weinstein and Sandman’s revised PAPM outlines
Table I. Participant characteristics
Characteristic N (%)
Age






Non-Hispanic white 132 (28%)
Non-Hispanic African American 198 (42%)





Married or living with partner 155 (33%)
Divorced or separated 171 (36%)
Widowed or never married 144 (31%)
Education
High school or below 281 (60%)


















Perceived risk (range: 3–9)
Mean perceived risk (±SD) 4.9 (1.5)
Fatalism score (range: 10–30)
Mean fatalism score (±SD) 24.1 (3.4)
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several possible reasons that an individual may not
have adopted a given preventive health behavior
[26]. All people who have not acted are not the
same, and determining where in the decision-
making process they are should allow researchers
to design more effective interventions.
Recognizing that not all people start at the same
decisional stage and thus might not have the same
interventional needs could help improve the efficacy
of intervention efforts [12]. In this analysis of base-
line data from racially and ethnically diverse (see
Table I), low-income participants enrolled in a CRC
screening intervention, we wanted to characterize
and better understand the decisional diversity in par-
ticipants pre-intervention to distinguish among the
following: (i) people who were completely unaware
of CRC screening methods (Stage 1); (ii) people
who did not feel that CRC screening was relevant
to them (i.e. not engaged; Stage 2); (iii) people who
were aware, engaged and trying to decide whether or
not to screen for CRC, and if so, what screening
method to use (Stage 3) and (iv) people who had
already thought about screening and actively
decided against it (Stage 4). From a preventive
care perspective, those who have already decided
to screen and have chosen their preferred screening
method (Stage 5) may be in need of screening
opportunities and assistance overcoming barriers
to screening, rather than intensive education.
Those who have already adopted a screening behav-
ior (Stage 6) and remain up to date with screening
over time (Stage 7) were not eligible for this study
and are unlikely to need intervention.
Information about decisional stage distribution
for CRC screening among the underserved, and
not necessarily their ultimate screening completion,
is crucial for better targeting efforts to increase sub-
optimal screening rates in these populations. We
found a large percentage (82.3%, Fig. 3A) of our
study population had heard of at least one CRC
screening method; however, nearly 18% of our par-
ticipants were unaware of CRC screening options.
While we would expect that those in Stages 3
(deciding) and 5 (decided to) are likely to eventually
get screened, those in Stages 1 (unaware) and 2 (un-
engaged) are at most risk of not making a final de-
cision about being screened. Our findings indicate
that interventions tailored to underserved popula-
tions in Stages 1 and 2 that are designed to move
people forward in the decision-making process by
Table II. Odds ratios, 95% confidence intervals and P-values obtained from the baseline logit models
CRC screening method Stage 2 Stage 3 Stage 5
OR (95% CI) P OR (95% CI) P OR (95% CI) P
SBTa
Female sex 2.40 (1.43, 4.03) 0.0009* 3.00 (1.10, 8.17) 0.031* 1.84 (0.90, 3.77) 0.10
English language 2.80 (1.22, 6.39) 0.015* 4.58 (1.24, 17.0) 0.023* 3.72 (1.14, 12.2) 0.030*
Doctor recommendation 3.19 (1.96, 5.19) <0.0001* 3.28 (1.33, 8.13) 0.010* 4.40 (2.12, 9.10) <0.0001*
Colonoscopyb
English language 3.68 (1.40, 9.68) 0.008* 1.15 (0.42, 3.17) 0.79 0.97 (0.43, 2.19) 0.93
College education or higher 2.00 (0.96, 4.17) 0.07 3.16 (1.44, 6.94) 0.004* 3.23 (1.62, 6.43) 0.0008*
Doctor recommendation 2.05 (1.09, 3.86) 0.025* 4.78 (2.41, 9.49) <0.0001* 3.03 (1.71, 5.36) 0.0001*
Self-efficacy 0.79 (0.43, 1.45) 0.44 1.30 (0.67, 2.53) 0.43 2.06 (1.18, 3.60) 0.011*
Overallc
Female sex 3.43 (1.72, 6.83) 0.0005* 3.22 (1.54, 6.74) 0.002* 2.73 (1.46, 5.11) 0.002*
College education or higher 1.75 (0.76, 4.04) 0.19 3.32 (1.38, 7.96) 0.007* 3.98 (1.82, 8.69) 0.0006*
Doctor recommendation 2.71 (1.33, 5.52) 0.006* 7.55 (3.52, 16.2) <0.0001* 5.61 (2.91, 10.8) <0.0001*
Self-efficacy 1.14 (0.59, 2.20) 0.69 1.81 (0.89, 3.69) 0.10 2.17 (1.18, 3.98) 0.013*
*Indicates statistical significance. aAdjusted for clinic, age, marital status, education, employment status, insurance status, self-
efficacy, perceived risk and fatalism. bAdjusted for clinic, age, gender, marital status, employment status, insurance status, perceived
risk and fatalism. cAdjusted for clinic, age, preferred language, marital status, employment status, insurance status, perceived risk
and fatalism. Variance inflation factor <2 for all explanatory variables.
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providing information necessary to raise awareness
and perceived susceptibility would be important in
this population.
Minority participants are well represented in our
sample (27% Hispanic, 42% non-Hispanic African
American, 28% non-Hispanic white and 3% non-
Hispanic other; Table I). African Americans and
Hispanics, especially Hispanics who speak primar-
ily Spanish, have not been well represented in stu-
dies on CRC screening decision making to date, and
members of these racial/ethnic groups have different
perceptions, barriers and influences on their deci-
sion-making process with regard to CRC screening
than whites [27–29].
It is important to note that we considered another
potential factor that could presumably influence
decisional stage for CRC: prior CRC screening ex-
perience. First, English-speaking participants were
more likely to have prior CRC screening experience
than Spanish-speaking participants, which could ex-
plain why more Spanish-speaking participants were
in Stage 1 (unaware) than English-speaking partici-
pants (Fig. 3). Because prior experience of CRC
screening was used to define PAPM staging (partici-
pants are above Stage 1 if they have had prior
screening), participants with prior screening were
all in Stages 2–5, and none were in Stage 1. As a
result of this, completion of prior screening and its
effect on stage could not be included in the full ana-
lysis model but were explored herein by polytomous
logistic regression, although the data from these ana-
lyses are not shown. A subset analyses using partici-
pants in Stages 2, 3 and 5 (n¼ 205 for SBT, n¼ 363
for colonoscopy and n¼ 387 for overall) revealed
that prior screening was not significantly associated
with PAPM staging (results not shown) for any
screening test.
Women were more likely than men to be unen-
gaged (Stage 2) or deciding (Stage 3) for SBT and
Stage 2, 3 or 5 (decided) for overall screening. In
2010, women and men had approximately equal
rates of CRC screening (58.8% for women, 58.5%
for men); however, in some studies of smaller
groups, women were less likely than men to be
up-to-date with CRC screening [30–32]. Other re-
ports have shown that men were more likely to be
screened by sigmoidoscopy or colonoscopy (by self-
report or medical data), whereas women were more
likely to be screened by SBT (self-report) [33]. Our
data suggest that women may be more likely to be
aware of and considering CRC screening than men,
but progress through the stages differently than men,
with men potentially moving from deciding to act
(Stage 5) to action (Stage 6) more quickly than
women.
A physician’s recommendation can be powerful
for promoting CRC screening. Multiple studies have
identified this association [34, 35]. In our study,
across screening methods, people with a doctor’s
recommendation were nearly eight times more
likely to be in Stage 3 (deciding whether or not to
screen) and nearly six times more likely to be in
Stage 5 (having decided in favor of screening)
versus Stage 1 (unaware of screening) than
those without such recommendation (Table II).
Interestingly, although Spanish-speaking partici-
pants were just as likely to report a doctor’s recom-
mendation to screen for CRC, they were less likely
than English-speaking participants to be aware of
specific screening methods (Fig. 3). This may be
due to language barriers with physicians who are
primarily English speaking. In addition, health liter-
acy could play an important role, as studies have
linked low English proficiency with poor health
and low screening rates [36–38]. Discussion of
screening may not be as detailed when there is a
language barrier or the patient may not understand
the explanation of tests provided.
Education is often a factor in screening participa-
tion. Our findings that participants with college edu-
cation or higher were more likely to be deciding
(Stage 3) or decided (Stage 5) than unaware (Stage
1) for colonoscopy and overall screening are con-
sistent with other studies where higher education is
associated with CRC screening uptake [39–41].
Despite low incomes, we see here that the relation-
ship between education and screening uptake per-
sists with decisional stage for CRC screening.
The highest level of self-efficacy was associated
only with decisional stage for colonoscopy, and the
association was strong enough to be a factor in over-
all decisional stage. It may be that the requirements
C. M. Hester et al.
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of colonoscopy preparation are high enough that
having very high self-efficacy for screening is essen-
tial for those deciding to screen using this method,
but less important in deciding to screen using SBT.
Future studies that address specific barriers for each
screening method may be able to address this finding
more fully.
Our data are useful for researchers and providers
alike because we report staging for SBT and colon-
oscopy independently, in addition to staging for
overall CRC screening. Knowing decisional stage
distribution by test type is important because colon-
oscopy may not a viable option for many people,
particularly those with low incomes, even when col-
onoscopy is preferred. SBT is simple and inexpen-
sive with far fewer logistical barriers to completion
than colonoscopy (i.e. no transportation required, no
laxative, no adherence to clinic schedules, etc.), al-
though social and psychological barriers can hinder
SBT completion. We found a disproportionate
number of participants who were unaware of SBT
as a screening method compared to colonoscopy
(56.2% of participants were in Stage 1 for SBT as
opposed to 21.5% in Stage 1 for colonoscopy;
Fig. 3A), with a striking lack of awareness of SBT
among Spanish speakers (Fig. 3C). Some studies
have shown that SBT is still preferred by some pa-
tients over colonoscopy, even when out of pocket
costs are equivalent [42]. For many low-income pa-
tients, having a low-cost, low-risk, time-effective
screening method may make the difference between
getting screened and not getting screened for CRC;
it is important to improve education and communi-
cation about this alternative.
The purpose of this initial study was to examine
decisional stage at study intake for a racially and
ethnically diverse group of low-income adults who
were not up to date with CRC screening. Decisional
stage information is useful for understanding and
identifying where patients are in considering screen-
ing and for better characterizing the interventional
needs of the group. The inherent diversity of
individuals makes a tailored approach critical for
maximum success in an intervention targeted at
individuals. Tailored interventions may be ideal
for overcoming obstacles to care and advancing a
patient’s decisional stage. Tailoring on appropriate
variables can truly meet the patient’s decisional
stage and psychosocial needs, diverting the limited
time available for intervention in clinics to where it
is most needed. Awareness of decisional stage
for this population should allow for the design of
more effective interventions that address the needs
of the patient and facilitate progression to the
next decisional stage. We gathered this baseline
information about decisional stage to inform a
tailored CRC screening intervention designed to
walk people through subsequent decisional stages
by heightening awareness of screening methods,
increasing the personal relevance of CRC risk,
asking questions that encourage engagement, elab-
oration and self-efficacy and encouraging personal
choice and commitment to undergoing CRC
screening.
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